FindTrial
Sign In

The Effects of Percutaneous Radiofrequency Ablation on the Peripheral Blood T cell subsets in Patients

The Effects of Percutaneous Radiofrequency Ablation on the Peripheral Blood T cell subsets in Patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-17012996
Enrollment
Unknown
Registered
2017-10-16
Start date
2017-10-01
Completion date
Unknown
Last updated
2017-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer

Interventions

Case series:Percutaneous Radiofrequency Ablation

Sponsors

the 2nd Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: All patients who are suitable for radiofrequency treatment

Exclusion criteria

Exclusion criteria: 1. Patients who have used immunosuppressive agents for nearly one month; 2. Uncontrolled seizures or psychiatric diseases, loss of control over their own behavior; 3. white blood cells 2.

Design outcomes

Primary

MeasureTime frame
Peripheral Blood T cell subsets;—

Countries

China

Contacts

Public ContactTao Xin

the 2nd Affiliated Hospital of Harbin Medical University

taoxinemail@126.com+86 13633655999

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026